analyst
EX
NASDAQ · EXEL
Exelixis, Inc.
Healthcare · Biotechnology
$56.90
Up+$0.37 (+0.64%)
Updated Sep 16, 2026, 3:50 PM
SID Score
7.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 11.1B
- P/E ratio
- 16.39
- Dividend yield
- 0.00%
- 52-week range
- $33.76 – $59.72
- Volume
- 1.98M
- Avg. volume
- 2.76M
Price performance
EXEL price history
1M range · 20 trading sessions · Daily adjusted prices
EXEL closed at $56.90 after 20 trading sessions, up 7.12% for the selected period.
- Last close
- $56.90
- Period change
- +7.12%
- Period low
- $53.12
- Period high
- $59.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $55.93 | $56.97 | $54.945 | $56.90 | 1.98M |
| Sep 14, 2026 | $56.44 | $57.07 | $55.91 | $56.21 | 1.74M |
| Sep 11, 2026 | $56.76 | $57.43 | $54.545 | $56.12 | 2.92M |
| Sep 10, 2026 | $58.33 | $58.33 | $57.23 | $57.43 | 1.79M |
| Sep 9, 2026 | $57.60 | $58.36 | $56.95 | $58.33 | 1.77M |
| Sep 8, 2026 | $58.97 | $59.41 | $57.55 | $57.67 | 2.54M |
| Sep 4, 2026 | $58.502 | $59.255 | $58.455 | $59.01 | 1.58M |
| Sep 3, 2026 | $58.75 | $59.72 | $58.195 | $59.13 | 2.14M |
| Sep 2, 2026 | $57.21 | $59.11 | $56.695 | $58.53 | 2.85M |
| Sep 1, 2026 | $54.75 | $56.97 | $54.75 | $56.89 | 2.41M |
| Aug 31, 2026 | $54.10 | $55.02 | $53.4283 | $54.64 | 2.25M |
| Aug 28, 2026 | $55.14 | $55.25 | $54.12 | $54.45 | 1.49M |
| Aug 27, 2026 | $55.76 | $56.08 | $54.83 | $55.26 | 1.49M |
| Aug 26, 2026 | $56.54 | $56.90 | $56.06 | $56.10 | 1.82M |
| Aug 25, 2026 | $54.95 | $56.74 | $54.95 | $56.72 | 2.02M |
| Aug 24, 2026 | $53.89 | $54.79 | $53.39 | $54.55 | 2.42M |
| Aug 21, 2026 | $53.74 | $54.68 | $53.70 | $54.08 | 1.95M |
| Aug 20, 2026 | $53.76 | $54.50 | $53.44 | $53.69 | 1.95M |
| Aug 19, 2026 | $53.46 | $54.58 | $53.10 | $54.39 | 2.5M |
| Aug 18, 2026 | $52.32 | $53.36 | $52.11 | $53.12 | 1.29M |
Latest EXEL news
The latest Smart Investors Daily articles mentioning EXEL.
Stock researchMarket Activity · Short Interest
Loading stock research…